Literature DB >> 33258546

The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.

Gabriela Oates1, Sarah Rutland1, Lucia Juarez1, Annabelle Friedman1, Michael S Schechter2.   

Abstract

BACKGROUND: Differences in socioenvironmental exposures influence overall child health, but their association with pediatric cystic fibrosis (CF) outcomes is less clear. This observational study investigated the relationship between area-level socioeconomic deprivation, state child health, and CF respiratory outcomes in a national cohort.
METHODS: We assessed relationships between the 2015 area deprivation index, a composite measure of socioeconomic disadvantage; the 2016 child health index, a state-specific measure of overall child health; and CF respiratory outcomes in the 2016 CF Foundation Patient Registry.
RESULTS: The sample included 9934 individuals with CF, aged 6-18 years. In multiple regression analysis adjusted for demographic and clinical covariates, those residing in the worst tertile for area deprivation had 2.8% lower percent predicted forced expiratory volume in 1 s (ppFEV1 ; 95% confidence interval [CI]: -4.1 to -1.5), 1.2 more intravenous (IV) treatment nights (CI: 0.1-2.4), and 20% higher odds of ≥2 pulmonary exacerbations (odds ratio [OR]: 1.2, CI: 1.0-1.5) than best-tertile counterparts. Children with CF in states at the worst tertile for child health had 2.3% lower ppFEV1 (CI: -4.5 to -0.2), 2.2 more IV treatment nights (CI: 0.5-3.6), and 40% higher odds of ≥2 exacerbations (OR: 1.4, CI: 1.1-1.8) than best-tertile counterparts. State child health accounted for the association between area deprivation and multiple exacerbations and more IV treatment nights.
CONCLUSIONS: Both area socioeconomic characteristics and state child health play a role in pediatric CF outcomes. The residual association of the state child health with CF outcomes after controlling for area deprivation reflects the ability of state programs to mitigate the effect of poverty.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  cystic fibrosis; social dimensions of pulmonary medicine

Mesh:

Year:  2020        PMID: 33258546      PMCID: PMC8035176          DOI: 10.1002/ppul.25192

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  40 in total

Review 1.  Low income/socio-economic status in early childhood and physical health in later childhood/adolescence: a systematic review.

Authors:  Nick Spencer; Tu Mai Thanh; Séguin Louise
Journal:  Matern Child Health J       Date:  2013-04

2.  Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas.

Authors:  Amy J H Kind; William R Buckingham
Journal:  N Engl J Med       Date:  2018-06-28       Impact factor: 91.245

3.  The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.

Authors:  M S Schechter; B J Shelton; P A Margolis; S C Fitzsimmons
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

4.  Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.

Authors:  Michael S Schechter; Susanna A McColley; Stefanie Silva; Tmirah Haselkorn; Michael W Konstan; Jeffrey S Wagener
Journal:  J Pediatr       Date:  2009-07-16       Impact factor: 4.406

5.  A review of cystic fibrosis children born to single mothers.

Authors:  C Macpherson; A O Redmond; A Leavy; M McMullan
Journal:  Acta Paediatr       Date:  1998-04       Impact factor: 2.299

6.  Contributors to excess infant mortality in the U.S. South.

Authors:  Ashley H Hirai; William M Sappenfield; Michael D Kogan; Wanda D Barfield; David A Goodman; Reem M Ghandour; Michael C Lu
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

Review 7.  Socioeconomic status and health outcomes: cystic fibrosis as a model.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2016-06-09       Impact factor: 3.772

8.  Cardiometabolic Dysfunction Among U.S. Adolescents and Area-Level Poverty: Race/Ethnicity-Specific Associations.

Authors:  Andrew D Williams; Edmond Shenassa; Natalie Slopen; Lauren Rossen
Journal:  J Adolesc Health       Date:  2018-11       Impact factor: 5.012

9.  A multimethodological analysis of cumulative risk and allostatic load among rural children.

Authors:  Gary W Evans
Journal:  Dev Psychol       Date:  2003-09

10.  Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Authors:  Jonathan Cogen; Julia Emerson; Don B Sanders; Clement Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Pediatr Pulmonol       Date:  2015-06-09
View more
  5 in total

Review 1.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

2.  Experiences and Perspectives of Individuals with Cystic Fibrosis and Their Families Related to Food Insecurity.

Authors:  Montserrat A Corbera-Hincapie; Samar E Atteih; Olivia M Stransky; Daniel J Weiner; Iris M Yann; Traci M Kazmerski
Journal:  Nutrients       Date:  2022-06-21       Impact factor: 6.706

3.  Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia.

Authors:  Emma Banwell; Joseph M Collaco; Gabriela R Oates; Jessica L Rice; Lucia D Juarez; Lisa R Young; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2022-05-21

4.  Geospatial Analysis of Food Deserts and Their Impact on Health Outcomes in Children with Cystic Fibrosis.

Authors:  Montserrat A Corbera-Hincapie; Kristen S Kurland; Mark R Hincapie; Anthony Fabio; Daniel J Weiner; Sandra C Kim; Traci M Kazmerski
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

5.  The life rafts sailed; Now let's take stock and set the course ahead (Commentary).

Authors:  Jane C Davies
Journal:  J Cyst Fibros       Date:  2021-12       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.